2-Butyl-3-(p-tolyl)quinuclidine (BTQ) is a stimulant DRI. It is one of a number of substituted quinuclidine derivatives developed as potential medications for the treatment of cocaine abuse and produces similar effects to cocaine in animal studies although milder and longer lasting.
This page contains content from the copyrighted Wikipedia article "Butyltolylquinuclidine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
